ESMO Asia 2016 Congress

Oncology Meeting Resources

16 Dec - 19 Dec 2016, Singapore

ESMO Asia 2016 Square

The ESMO Asia Congress comprised both scientific and educational tracks prepared by an international scientific committee. There was a strong emphasis on state of the art science, including a call for abstracts, and the current standard of care across all major tumour types.

Abstracts, presentations and webcasts from the ESMO Asia 2016 Congress are now available here to ESMO members. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Useful Links

Format available

BackgroundIn colorectal cancer (CRC), the possibility of lymph node (LN) metastases is important to select the treatment. According to the Japanese Society for Cancer of the Colon and Rectum guidelines...

Date: 19 Dec 2016
Presenter: Shiki Fujino
Resources: Abstract
Topics: Colon Cancer, Rectal Cancer, Pathology/Molecular Biology

BackgroundMedian overall survival (OS) for first-line (1L) treatment of advanced hepatocellular carcinoma (aHCC) with sorafenib (sor) is up to 11 mo and 7–8 mo with best supportive care (BSC) post-sor failure.

Date: 19 Dec 2016
Presenter: Ignacio Melero
Resources: Abstract
Topics: Hepatobiliary Cancers, Cancer Immunology and Immunotherapy